UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 15, 2026
Accession Number:
0001104659-26-083007
Submission Type:
POS AM
CIK:
0001434868
Company Name:
Esperion Therapeutics, Inc.
File Number:
333-286631